https://roberts-communications.com/wp-content/uploads/2020/11/5_art_image.800_0_1.jpg
326
800
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:51:292020-11-27 22:51:29Overcoming Skin Assay Challenges with Living Human Models
https://roberts-communications.com/wp-content/uploads/2020/11/5_art_image.800_0_1.jpg
326
800
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:39:422020-11-27 22:39:42No need for animal testing: improving vaccine research with Genoskin
https://roberts-communications.com/wp-content/uploads/2020/11/S1-CFOTL-Badges-1.png
311
600
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:34:012020-11-27 22:34:01640: Communicating Your Strategic Plan | James Samuels, CFO, EXUMA Biotech
https://roberts-communications.com/wp-content/uploads/2020/11/Exuma-spareW.jpg
675
1104
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:24:042020-11-27 22:24:04EXUMA readies solid tumour cell therapy treatment for the clinic.
https://roberts-communications.com/wp-content/uploads/2020/11/375_250-istock_1054573988.jpg
250
375
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:20:122020-11-27 22:20:12How Big Data Is Accelerating EXUMA Biotech In The Race To Rapid CAR-T Therapy
https://roberts-communications.com/wp-content/uploads/2020/11/15fc9f45397fd96e8072192fd57dec9756ac6441-960x689-1.jpg
689
960
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:11:562020-11-27 22:11:56Expanding Access to CAR-T: Dr. Greg Frost
https://roberts-communications.com/wp-content/uploads/2020/11/shutterstock_581843374_cover.jpg
391
880
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2020-11-27 22:08:382020-11-27 22:08:38Lilly I-O exec jumps to CAR-T biotech Exuma
https://roberts-communications.com/wp-content/uploads/2019/08/Benzinga.jpg
768
1024
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2019-08-09 14:18:372019-08-13 11:02:00BioXcel’s CEO On BXCL501: ‘This Is A Pretty Unique Drug’
https://roberts-communications.com/wp-content/uploads/2019/08/NBC-News-Photo.jpg
1000
2000
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2019-08-09 14:07:212019-08-22 02:43:39Is Targeting Brain Inflammation The Key to Beating Alzheimer’s Disease?
https://roberts-communications.com/wp-content/uploads/2019/08/Opioid-Photo.jpg
393
700
Judd
https://roberts-communications.com/wp-content/uploads/2019/08/logo-rc-300x45.png
Judd2019-08-06 17:56:202019-08-09 13:30:53Finger Pointing Won’t Solve the Opioid Crisis. Innovation Will
Overcoming Skin Assay Challenges with Living Human Models
/0 Comments/in News /by JuddNo need for animal testing: improving vaccine research with Genoskin
/0 Comments/in News /by Judd640: Communicating Your Strategic Plan | James Samuels, CFO, EXUMA Biotech
/0 Comments/in News /by JuddEXUMA readies solid tumour cell therapy treatment for the clinic.
/0 Comments/in News /by JuddHow Big Data Is Accelerating EXUMA Biotech In The Race To Rapid CAR-T Therapy
/0 Comments/in News /by JuddExpanding Access to CAR-T: Dr. Greg Frost
/0 Comments/in News /by JuddLilly I-O exec jumps to CAR-T biotech Exuma
/0 Comments/in News /by JuddBioXcel’s CEO On BXCL501: ‘This Is A Pretty Unique Drug’
/0 Comments/in News /by JuddIs Targeting Brain Inflammation The Key to Beating Alzheimer’s Disease?
/0 Comments/in News /by JuddFinger Pointing Won’t Solve the Opioid Crisis. Innovation Will
/0 Comments/in News /by Judd